Keyword: Genzyme

The Orphan Chase (1/16/2006)

Orphan drugs are profitable because of third-party health insurance and favorable regulatory oversight.

Keywords: charity, Gaucher disease, generic, Genzyme, orphan drug, price discrimination, regulation